Skip to main content

Advertisement

Log in

Prediction of Colorectal Cancer or Colonic Neoplasia Risk: From Symptoms to Scores

  • Prevention and Early Detection (R Benamouzig, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

A large part of colorectal cancer (CRC) could be prevented if our current knowledge of risk factors was used to identify high-risk patients and to provide them efficient and adapted screening. Algorithms allowing the estimation of the individual risk of currently having or developing a CRC has been developed. Though these scores have a real potential in triage ability, their clinical impact as triage tools or to design tailored preventive action remains poor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–502. Excellent synthetic review on colorectal cancer prevention.

    Article  PubMed  Google Scholar 

  2. Jellema P, van der Windt DA, Bruinvels DJ, et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis. BMJ. 2010;340:1269.

    Article  Google Scholar 

  3. Olde Bekkink M, McCowan C, Falk GA, et al. Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer. Br J Cancer. 2010;102:48–58.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Astin M, Griffin T, Neal RD, et al. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract. 2011;61:231–43.

    Article  Google Scholar 

  5. Hippisley-Cox J, Coupland C. Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2012;62:29–37. Prospective evaluation of predictive value of clinical symptoms for CRC diagnosis.

    Article  Google Scholar 

  6. Jones R, Latinovic R, Charlton J, et al. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ. 2007;334:1040.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Nakama H, Zhang B, Fukazawa K, et al. Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer. Eur J Cancer. 2000;36:2111–4.

    Article  CAS  PubMed  Google Scholar 

  8. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216–27.

    Article  PubMed  Google Scholar 

  9. Baglietto L, Jenkins MA, Severi G, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol. 2006;59:114–24.

    Article  PubMed  Google Scholar 

  10. Cottet V, Pariente A, Nalet B, et al. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology. 2007;133:1086–92.

    Article  PubMed  Google Scholar 

  11. Nguyen SP, Bent S, Chen YH, et al. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:676–81.

    Article  PubMed  Google Scholar 

  12. Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012;156:703–9. Review and critical methodological approach to determine the risk of colorectal neoplasia in persons with a family history of adenomatous polyp.

    Article  PubMed  Google Scholar 

  13. Johnson CM, Wei C, Ensor JE, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207–22. Systematic quantification of risk ratio for main CRC risk factors.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Tuohy TM, Rowe KG, Mineau GP, et al. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer. 2014;120:35–42.

    Article  PubMed  Google Scholar 

  15. Aleksandrova K, Pischon T, Jenab M, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 2014;12:168. Quantification of protective effects of healthy lifestyle factors in a large European cohort with 12 years of follow-up.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Jiang Y, Ben Q, Shen H, et al. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2011;26:863–76.

    Article  PubMed  Google Scholar 

  17. Yusof AS, Isa ZM, Shah SA. Dietary patterns and risk of colorectal cancer: a systematic review of cohort studies (2000–2011). Asian Pac J Cancer Prev. 2012;13:4713–7.

    Article  PubMed  Google Scholar 

  18. Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer. 2009;61:47–69.

    Article  CAS  PubMed  Google Scholar 

  19. Keum N, Aune D, Greenwood DC, et al. Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int J Cancer. 2014;135:1940–8.

    Article  CAS  PubMed  Google Scholar 

  20. Ye X, Fu J, Yang Y, et al. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One. 2013;8:57578.

    Article  Google Scholar 

  21. Aune D, Chan DS, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011;343:6617.

    Article  Google Scholar 

  22. Aune D, Lau R, Chan DS, et al. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol. 2012;23:37–45.

    Article  CAS  PubMed  Google Scholar 

  23. Ralston RA, Truby H, Palermo CE, et al. Colorectal cancer and nonfermented milk, solid cheese, and fermented milk consumption: a systematic review and meta-analysis of prospective studies. Crit Rev Food Sci Nutr. 2014;54:1167–79.

    Article  CAS  PubMed  Google Scholar 

  24. Ordonez Mena JM, Brenner H. Vitamin D and cancer: an overview on epidemiological studies. Adv Exp Med Biol. 2014;810:17–32.

    PubMed  Google Scholar 

  25. Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013;9, CD009259.

    PubMed  Google Scholar 

  26. Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Launois R, Le Moine JG, Uzzan B, et al. Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. Eur J Gastroenterol Hepatol. 2014;26:978–89.

    Article  CAS  PubMed  Google Scholar 

  28. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:2467. Review of evidence concerning colonic endoscopical screening.

    Article  Google Scholar 

  29. Jiao S, Peters U, Berndt S, et al. Estimating the heritability of colorectal cancer. Hum Mol Genet. 2014;23:3898–905.

    Article  CAS  PubMed  Google Scholar 

  30. Peters U, Jiao S, Schumacher FR, et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology. 2013;144:799–807.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Zhang K, Civan J, Mukherjee S, et al. Genetic variations in colorectal cancer risk and clinical outcome. World J Gastroenterol. 2014;20:4167–77.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Whiffin N, Hosking FJ, Farrington SM, et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Hum Mol Genet. 2014;23:4729–37.

    Article  CAS  PubMed  Google Scholar 

  33. Houlston RS. COGENT (COlorectal cancer GENeTics) revisited. Mutagenesis. 2012;27:143–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Win AK, Macinnis RJ, Hopper JL, et al. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev. 2012;21:398–410.

    Article  PubMed  Google Scholar 

  35. Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12:1624–34.

    Article  PubMed  Google Scholar 

  36. Win AK, Macinnis RJ, Dowty JG, et al. Criteria and prediction models for mismatch repair gene mutations: a review. J Med Genet. 2013;50:785–93.

    Article  CAS  PubMed  Google Scholar 

  37. Brazer SR, Pancotto FS, Long TT, et al. Using ordinal logistic regression to estimate the likelihood of colorectal neoplasia. J Clin Epidemiol. 1991;44:1263–70.

    Article  CAS  PubMed  Google Scholar 

  38. Selvachandran SN, Hodder RJ, Ballal MS, et al. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet. 2002;360:278–83.

    Article  CAS  PubMed  Google Scholar 

  39. Betes M, Munoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98:2648–54.

    PubMed  Google Scholar 

  40. Church JM. A scoring system for the strength of a family history of colorectal cancer. Dis Colon Rectum. 2005;48:889–96.

    Article  PubMed  Google Scholar 

  41. Driver JA, Gaziano JM, Gelber RP, et al. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–63.

    Article  PubMed  Google Scholar 

  42. Wei EK, Colditz GA, Giovannucci EL, et al. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study. Am J Epidemiol. 2009;170:863–72.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Omata F, Shintani A, Isozaki M, et al. Diagnostic performance of quantitative fecal immunochemical test and multivariate prediction model for colorectal neoplasms in asymptomatic individuals. Eur J Gastroenterol Hepatol. 2011;23:1036–41.

    CAS  PubMed  Google Scholar 

  44. Jo J, Nam CM, Sull JW, et al. Prediction of colorectal cancer risk using a genetic risk score: The Korean Cancer Prevention Study-II (KCPS-II). Genomics Inform. 2012;10:175–83.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 63:466–71. Evaluation of the role of scoring for CRC in population with fecal occult blood test.

  46. Orannapalai N, Attawettayanon W, Kanngern S, et al. Predicting the occurrence of cancer-associated colorectal polyp using a metabolic risk score. Mol Clin Oncol. 2014;2:124–8.

    PubMed Central  PubMed  Google Scholar 

  47. Wells BJ, Kattan MW, Cooper GS, et al. ColoRectal Cancer Predicted Risk Online (CRC-PRO) calculator using data from the Multi-Ethnic Cohort Study. J Am Board Fam Med. 2014;27:42–55.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Chen G, Mao B, Pan Q, et al. Prediction rule for estimating advanced colorectal neoplasm risk in average-risk populations in southern Jiangsu Province. Chin J Cancer Res. 2014;26:4–11.

    CAS  PubMed Central  PubMed  Google Scholar 

  49. Law CW, Rampal S, Roslani AC, et al. Development of a risk score to stratify symptomatic adults referred for colonoscopy. J Gastroenterol Hepatol. 2014 (in press).

  50. Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000;11:477–88.

    Article  CAS  PubMed  Google Scholar 

  51. Ma E, Sasazuki S, Iwasaki M, et al. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34:534–41.

    Article  PubMed  Google Scholar 

  52. Steffen A, MacInnis RJ, Joshy G, et al. Development and validation of a risk score predicting risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2014 (in press).

  53. Shin A, Joo J, Yang HR, et al. Risk prediction model for colorectal cancer: National Health Insurance Corporation study, Korea. PLoS One. 2014;9:88079.

    Article  Google Scholar 

  54. Imperiale TF, Wagner DR, Lin CY, et al. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med. 2003;139:959–65.

    Article  PubMed  Google Scholar 

  55. Lin OS, Kozarek RA, Schembre DB, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology. 2006;131:1011–9.

    Article  PubMed  Google Scholar 

  56. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–93.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–8.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Kastrinos F, Allen JI, Stockwell DH, et al. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol. 2009;104:1508–18.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–41.

    Article  PubMed  Google Scholar 

  60. Levitzky BE, Brown CC, Heeren TC, et al. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011;106:1099–106.

    Article  PubMed  Google Scholar 

  61. Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol. 2012;175:584–93.

    Article  PubMed  Google Scholar 

  62. Park HW, Han S, Lee JS, et al. Risk stratification for advanced proximal colon neoplasm and individualized endoscopic screening for colorectal cancer by a risk-scoring model. Gastrointest Endosc. 2012;76:818–28.

    Article  PubMed  Google Scholar 

  63. Schroy PC, Coe AM, Mylvaganam SR, et al. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila). 2012;5:1044–52.

    Article  Google Scholar 

  64. Bouwens MW, Winkens B, Rondagh EJ, et al. Simple clinical risk score identifies patients with serrated polyps in routine practice. Cancer Prev Res. 2013;6:855–63.

    Article  Google Scholar 

  65. Kaminski MF, Polkowski M, Kraszewska E, et al. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–9.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol. 2014;12:478–85.

    Article  PubMed  Google Scholar 

  67. Wong MC, Lam TY, Tsoi KK, et al. Predictors of advanced colorectal neoplasia for colorectal cancer screening. Am J Prev Med. 2014;46:433–9.

    Article  PubMed  Google Scholar 

  68. Yarnall JM, Crouch DJ, Lewis CM. Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer. Cancer Epidemiol. 2013;37:324–9.

    Article  PubMed  Google Scholar 

  69. Imperiale TF, Juluri R, Sherer EA, et al. A risk index for advanced neoplasia on the second surveillance colonoscopy in patients with previous adenomatous polyps. Gastrointest Endosc. 2014;80:471–8.

    Article  PubMed  Google Scholar 

  70. Kim DJ, Rockhill B, Colditz GA.Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol. 2004;57:332–40.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Robert Benamouzig declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Benamouzig.

Additional information

This article is part of the Topical Collection on Prevention and Early Detection

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benamouzig, R. Prediction of Colorectal Cancer or Colonic Neoplasia Risk: From Symptoms to Scores. Curr Colorectal Cancer Rep 11, 17–28 (2015). https://doi.org/10.1007/s11888-014-0254-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-014-0254-1

Keywords

Navigation